Join us for this exciting presentation on Tuesday, April 18 at 2pm et!

Akkermansia muciniphila is on the forefront of microbiome research, touted for its ability to strengthen gut barrier function and produce health-promoting short chain fatty acids. Learn from Colleen Cutcliffe, co-founder and CEO of Pendulum Therapeutics, about the emerging science linking Akkermansia to healthy weight, intestinal integrity, and other health outcomes that may improve the way we age.

Key Points:
During this informative webinar, Colleen will discuss
• Akkermansia's important role in overall gut health and homeostasis
• Emerging research on Akkermansia and metabolic diseases
• Additional "boosters" to help increase the efficacy and abundance of Akkermansia

Details About the Webinar

About the Speaker

1679430563-f76c81bbb285c1d6 Colleen Cutcliffe, PhD

Colleen Cutcliffe is the Chief Executive Officer and co-founder of Pendulum. She has more than 20 years of experience leading and managing biology teams in academia, pharmaceuticals, and biotechnology. Prior to starting Pendulum, Colleen was the senior manager of biology at Pacific Biosciences and a scientist at Elan Pharmaceuticals. Colleen completed her postdoctoral studies at Northwestern’s Children’s Memorial Hospital. Colleen received her Ph.D. in Biochemistry and Molecular Biology from John Hopkins University and her B.A. in Biochemistry from Wellesley College.

Register To Watch Recording
First Name*
Last Name*
Email Address*
Zip Code*
What type of practitioner are you?*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.
Powered by BigMarker